Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 403-730-1 | CAS number: 2687-96-9
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Genetic toxicity in vitro, the following studies are available:
1) An Ames assay was conducted under OECD 471 using Salmonella tester strains (Jones, 1989). Key study.
It is concluded that no evidence of mutagenic potential of the test substance was obtained in this bacterial test system at the dose levels used.
2) Another Ames assay was conducted using Salmonella tester strains (Lavelle, 1986). Supporting study.
3) A GLP-compliant mouse lymphoma assay performed by SITEK Research Laboratories with N-Octylpyrrolidone is available, which can be used to address this endpoint for N-(n-dodecyl) pyrrolidinone. As pointed out in chapter 4 of the Read-Across-justification report, these two molecules show analogue alerts with respect to DNA and protein binding potency. Further, both molecules proved to be negative for mutagenicity in the Ames test. Consequently, this justifies the use of the Mouse lymphoma assay performed with N-(n-octyl)- 2-pyrrolidinone for addressing this endpoint for N-(n-dodecyl)pyrrolidinone.
Under conditions of this study, the test substance was found to be nonmutagenic in either with or without S-9 metabolic activation.
4) Cytogenetic assay in-vitro study: waived based upon REACH Annex VIII Section 8.4.2 column 2 on grounds that adequate data from a reliable in vivo mutagenicity study are available which shows a clear negative result.
Short description of key information:
Negative based on the following studies:
1) An Ames assay was conducted under OECD 471 using Salmonella tester strains (Jones, 1989). Key study.
2) Another Ames assay was conducted using Salmonella tester strains (Lavelle, 1986). Supporting study.
3) A GLP-compliant mouse lymphoma assay performed with N-Octylpyrrolidone is available, which can be used to address this endpoint for N-(n-dodecyl) pyrrolidinone.
4) Cytogenetic assay in-vitro study: waived based upon REACH Annex VIII Section 8.4.2 column 2 on grounds that adequate data from a reliable in vivo mutagenicity study are available which shows a clear negative result.
5) Genetic toxicity in vivo: A mouse micronucleus test which is key study.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Genetic toxicity: Both in-vitro Ames and mouse lymphoma test and in-vivo mouse micronucleus test give negative results.
Therefore in accordance with Regulation (EC) No. 1272/2008 Table 3.5.1 the substance is not classified for genetic toxicity endpoint.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
